Related Experiment Video
Updated: Jun 15, 2026
07:30
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
9.4K
[Guillain-Barre syndrome in children]
A A Kozyreva1,2, R Ts Bembeeva1,2, E S Druzhinina1,2
1Pirogov Russian National Research Medical University, Moscow, Russia.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|November 9, 2023
Summary
Guillain-Barré syndrome (GBS) is an immune disorder affecting the nervous system, causing progressive muscle weakness. Early diagnosis and treatment are crucial, especially in children, due to potential life-threatening complications.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Guillain-Barré syndrome (GBS) is an immune-mediated peripheral nervous system disorder.
- It presents as progressive, symmetrical, ascending muscle weakness in children and adults.
- Life-threatening complications include respiratory failure and autonomic dysfunction, necessitating vigilant monitoring.
Approach:
- This review analyzes current medical literature on pediatric GBS.
- It discusses diagnostic strategies and management tactics for GBS.
- The review incorporates Russian and European clinical recommendations for GBS patient care.
Key Points:
- GBS diagnosis can be challenging due to its expanding spectrum and atypical presentations.
- Timely pathogenetic therapy is vital for favorable outcomes, particularly in pediatric cases.
- Meticulous patient monitoring is essential to manage potential severe complications.
Conclusions:
- Effective management of pediatric Guillain-Barré syndrome requires early recognition and prompt, guideline-adherent treatment.
- Understanding the evolving diagnostic criteria and management protocols is key for clinicians.
- This review synthesizes current knowledge to aid in diagnosing and treating GBS in children.
Keywords:
flaccid paralysispediatric Guillain—Barre syndromepediatric acute inflammatory demyelinating polyneuropathypolyradiculoneuropathyMore Related Videos
Related Concept Videos
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...